By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Twitter Recognizes Boehringer Ingelheim as a Pioneer
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Medical Education > Twitter Recognizes Boehringer Ingelheim as a Pioneer
BusinessMedical EducationSocial Media

Twitter Recognizes Boehringer Ingelheim as a Pioneer

Paul Tunnah
Paul Tunnah
Share
4 Min Read
Twitter Recognizes Boehringer Ingelheim
SHARE

Twitter Recognizes Boehringer IngelheimI have written previously about how powerful I think Twitter is as a channel for a regulated industry like pharmaceuticals.

Twitter Recognizes Boehringer IngelheimI have written previously about how powerful I think Twitter is as a channel for a regulated industry like pharmaceuticals. It allows social media engagement with multiple personnel, but in controlled fashion that allows pharma companies to deal with problems in a controlled and compliant way.

Apparently one of the people who read that piece worked at Twitter and, unsurprisingly, they agreed with me!

It is great to therefore see the first business case study from the pharmaceutical industry appear on the Twitter.com website, featuring the work that social media pioneer Boehringer Ingelheim has been doing in using the social media channel to connect with other healthcare stakeholders.

More Read

Major Medicare Fraud Bust Just the Latest Lesson in Problematic Healthcare Spending
Why Medical Professionals Should Embrace Internet Marketing
Making Prevention a Priority
Is Technology a Cost Driver or a Cost Saver in Health Care?
Cancer Patient’s Compassionate Use Conundrum Leads to Social Media Ambush on BioMarin

The specific case study presented by Twitter is from the #COPDchat tweetchats that Boehringer Ingelheim has been running, but could equally have covered its engaging work in the atrial fibrillation or lung cancer space (which I am proud to have been involved in).

Of course, in keeping within the right regulatory guidelines that prevent direct prescription medicines promotion to patients outside the US, Boehringer’s work has focussed on tackling disease awareness issues and gathering research input from involved groups such as patient advocates, healthcare providers and disease associations, rather than discussing the merits of individual treatments.

Here, Boehringer Ingelheim outlines how it used Twitter to both approach and engage with relevant parties, positioning the discussion alongside a relevant medical conference – in this case the European Respiratory Society Congress (#ERS2013). In addition, promoted tweets were used to target specific attendees at the event, matching for keywords such as ‘asthma’ and ‘COPD’ as flags for relevance.

Links to press releases and further information were then used to provide additional background above and beyond the 140 characters permissible within a tweet, all of which sparked interest in the live tweetchat debate held during the congress.

And the results?

Well, the quantitative stats are pretty impressive. 1.7m tweetchat impressions from the hour’s live event, almost 500 mentions of Boehringer at the Congress and 1,200 new followers secured.

But the real story here is in the qualitative feedback gained from this tweetchat, and the numerous others Boehringer has run. Through such discussion the company gained valuable feedback on the market, which was spur-of-the-moment and reactive to developments at the Congress itself, in addition to opening doors with new organisations and individuals that can help its mission in the COPD space.

Twitter identified three key lessons from Boehringer’s work on tweetchats for other pharmaceutical companies:

  1. Align such online discussion with relevant offline events, like the Congress.
  2. Involve key internal stakeholders to ensure regulatory compliance.
  3. Be innovative – don’t be afraid to be the first in your sector rather than waiting for others.

With such prominence, quite rightly so, being given to Boehringer’s work it is time for other pharma companies to step up and also start driving such activities. Every pharma company is talking about being customer- and patient-focussed, and indeed the individuals working within these companies are passionate about making a difference, so communications teams need to start facilitating more of this work.

Boehringer has cut a path through the long grass for the rest of the industry. It’s time for others to start walking in their footsteps to help ensure everyone in healthcare can share their views on developing better medicines.

TAGGED:Boehringer Ingelheimpharmatwitter
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

dental care
Importance of Good Dental Care for Health and Confidence
Dental health Specialties
October 2, 2025
AI in Healthcare
AI in Healthcare: Technology is Transforming the Global Landscape
Global Healthcare Policy & Law Technology
October 1, 2025
Choosing the Right Swimwear for Health and Safety
News
September 30, 2025
sports concussions
Concussion In Sports: How Common They Are And What You Need To Know
Infographics
September 28, 2025

You Might also Like

UWPHI Health Outcomes
BusinessFinancePublic Health

14 Patient Barriers That May Delay or Prevent Recovery

September 4, 2014

Top 10 Takeaways from #SXSW2014: Part Two

April 8, 2014

Putting Physician Practices Into Context

December 12, 2012
Hospital AdministrationTechnology

Healthcare Software Testing for Seamless Stakeholders Experience

August 5, 2017
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?